Rusinol, L, Carmona-Rocha E., Puig L.. Durability and long-term outcomes of biologic therapies in psoriasis. Expert Review of Clinical Immunology. 2024; 20(1)DOI:10.1080/1744666X.2023.2250918. PMID:37610817. IF:3.700(Q2/5D).

Manzanares N., Vilarrasa E., López A., Alonso M.L., Velasco M., Riera J., del Alcázar E., Carrascosa J.M., Azón A., Rivera R., Santos S., Salgado-Boquete L., Roncero M., Dorado M., Yelamos O., Delgado C., Gallardo F., Ferran M.. No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024; 38(1)DOI:10.1111/jdv.19406. PMID:37561934. IF:8.000(Q1/1D).

Rusiñol, L, Puig, L. Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(2)DOI:10.3390/ijms25021042. PMID:38256115. IF:4.900(Q1/3D).

Navarro-Bielsa A., Gracia-Cazaña T., Almagro M., De-la-Fuente-Meira S., Florez Á., Yélamos O., Montero-Vilchez T., González-Cruz C., Diago A., Abadías-Granado I., Fuentelsaz V., Colmenero M., Bañuls J., Arias-Santiago S., Buendía-Eisman A., Almenara-Blasco M., Gil-Pallares P., Gilaberte Y.. Exposome and basal cell carcinoma: a multicenter case–control study. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(7)DOI:10.1111/ijd.17026. PMID:38282244. IF:3.200(Q1/3D).